Search clinical trials for: pramipexol

Total 140 results

Region Skane
Lund University

Recruiting

Long-term Efficacy of Pramipexole in Anhedonic Depression (LONG-PRAXOL)

Depression | Anhedonia

Sweden
Knopp Biosciences

Completed

Study in Healthy Volunteers of the Bioavailability of Dexpramipexole Tablets and Food Effects

Healthy Volunteers

United States
Neuropsychiatric Research Institute, Fargo, North...

Withdrawn

Pramipexole for Binge Eating Disorder

Binge Eating Disorder
Boehringer Ingelheim

Completed

Safety, Tolerability and Efficacy of Switching From Talipexole to Pramipexole in Patients With Parkinson's Disease

Parkinson Disease
Boehringer Ingelheim

Completed

Efficacy and Tolerability of Sifrol® (Pramipexole) in Patients With Advanced Idiopathic Parkinson's Disease

Parkinson Disease
Boehringer Ingelheim

Completed

Observational Study of Sifrol® in Patients With Primary Restless Legs Syndrome (RLS)

Restless Legs Syndrome
Knopp Biosciences

Completed

Phase 3 Study of Dexpramipexole in ALS (EMPOWER)

Amyotrophic Lateral Sclerosis

United States, United Kingdom, Netherlands, Spain, Belgium, Germany, Australia, Sweden, France, Ireland, Canada
Areteia Therapeutics

Recruiting

A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Eosinophilic Asthma (EXHALE-4)

Asthma Attack | Eosinophilic Asthma | Asthma; Eosinophilic

United States, United Kingdom, Romania, Poland
Boehringer Ingelheim

Completed

The Effect of Sifrol® on Tremor and Depression in Patients With Idiopathic Parkinson's Disease

Parkinson Disease
Knopp Biosciences

Completed

Dexpramipexole Renal PK Study

Renal Insufficiency | Amyotrophic Lateral Sclerosis

United States
Knopp Biosciences

Completed

Dexpramipexole Dose-Ranging Biomarker Study in Subjects With Eosinophilic Asthma (EXHALE-1)

Asthma | Eosinophilic Asthma

United States
Areteia Therapeutics

Enrolling by invitation

Phase III Long-Term Extension Study With Dexpramipexole (EXHALE-5)

Eosinophilic Asthma

United States
National Institute of Allergy and Infectious Diseases...
Knopp Biosciences

Unknown

Study to Evaluate Safety and Efficacy of Dexpramipexole (KNS-760704) in Subjects With Hypereosinophilic Syndrome

Hypereosinophilic Syndrome

United States
Knopp Biosciences

Completed

Dexpramipexole SAD/MAD Study

Amyotrophic Lateral Sclerosis

United States
Knopp Biosciences

Completed

Study of Dexpramipexole Chronic Sinusitis With Nasal Polyps and Eosinophilia (CS201)

Chronic Sinusitis With Nasal Polyps and Eosinophilia

United States
Massachusetts General Hospital

Recruiting

Treatment of Restless Legs Symptoms With Pramipexole to Improve the Outcomes of Protracted Opioid Withdrawal in OUD

Sleep Disorder | Restless Legs Syndrome | Opioid-use Disorder | Opioid Withdrawal

United States
Boehringer Ingelheim

Completed

Study to Investigate Pharmacokinetics (PK) of Pramipexole in Pediatric Patients Who Are Individually Optimized to Stable Pramipexole Doses for the Treatment of Idiopathic Restless Legs Syndrome (RLS)

Restless Legs Syndrome
Qualissima
H. Lundbeck A/S

Terminated

Evaluation of the Tolerance and Acceptability of Rasagiline in the Treatment of Early-stage Parkinson's Disease (ACTOR)

Early-stage Parkinson's Disease
Sheba Medical Center

Unknown

Minocycline, Acetylsalicylic Acid or Pramipexole vs Placebo in Patients With Schizophrenia or Schizoaffective Disorder (MAP-S-01)

Schizophrenia | Schizoaffective Disorder

Israel, Romania
Knopp Biosciences

Completed

Dexpramipexole and Warfarin Drug Drug Interaction (DDI) Study

Healthy Volunteers

United States
Boehringer Ingelheim

Completed

The Use of Pramipexole and Other Dopamine Agonists and the Risks of Heart Failure and Pneumonia

Heart Failure
Boehringer Ingelheim

Completed

Randomized Single-blind Placebo Controlled Comparative Trial of Pramipexole and Bromocriptine in Parkinson's Disease

Parkinson Disease

China
Rajesh Pahwa, MD
GlaxoSmithKline

Completed

Pramipexole Conversion to Ropinirole Controlled Release (CR)

Parkinson Disease

United States
Second Affiliated Hospital of Soochow University

Unknown

the Efficacy and Safety of Agomelatine in the Patients With Parkinson's Disease

Depression | Parkinson Disease | Sleep Disorders | Circadian Rhythm Disorders
Beth Israel Deaconess Medical Center

Recruiting

Gait Analysis in Neurological Disease

Parkinson's Disease | Parkinsonian Disorders | Multiple System Atrophy | Corticobasal Degeneration | Progressive Supranuclear Palsy | Huntington Disease | Atypical Parkinson Disease | Gait, Frontal

United States
Baylor College of Medicine
National Institute on Drug Abuse (NIDA)

Completed

Pramipexole as a Treatment for Cocaine Dependence

Substance Abuse | Cocaine Dependence | Cocaine Abuse | Cocaine Addiction

United States
Knopp Biosciences

Completed

Safety and Tolerability Study of KNS-760704 in Amyotrophic Lateral Sclerosis (ALS) (CL201)

Amyotrophic Lateral Sclerosis

United States
Clinical Academic Center (2CA-Braga)
University of Minho

Not yet recruiting

Efficacy of Treatment With Pramipexole or Risperidone in Patients With Refractory Obsessive-compulsive Disorder (OCD) (OCD-RT)

Obsessive-Compulsive Disorder
Dong Jie

Terminated

Pramipexole for Restless Leg Syndrome in Peritoneal Dialysis Patients

Restless Legs Syndrome

China
University Hospital Muenster

Suspended

Neuromodulation and Language Acquisition (Stage Ib)

Healthy

Germany
East Carolina University

Unknown

Pramipexole and Morphine for Renal Colic

Renal Colic

United States
Shanghai Mental Health Center

Completed

a Pilot Study of Pramipexole to Treat Extrapyramidal Symptoms Induced by Antipsychotics

Extrapyramidal Syndrome

China
Knopp Biosciences

Completed

Study to Evaluate the QTC Interval in Healthy Volunteers Dosed With Dexpramipexole (QTC = Electrocardiogram (ECG) Interval Measured From the Onset of the QRS Complex to the End of the T Wave Corrected for Heart Rate)

Amyotrophic Lateral Sclerosis

United States
Boehringer Ingelheim

Completed

Ophthalmologic Safety of Long Term Treatment With Pramipexole Compared to Bromocriptine or Other Dopamine Agonists in Patients With Parkinson's Disease

Parkinson Disease
National Institute of Mental Health (NIMH)

Completed

Lexapro and Pramipexole and to Treat Major Depression

Major Depression

United States
Teva Neuroscience, Inc.

Completed

A Non-Blinded Study Demonstrating the Effectiveness and Safety of Azilect Alone or in Combination Therapy in Parkinson's Disease

Parkinson's Disease
Knopp Biosciences

Completed

Dexpramipexole and Cimetidine Drug Drug Interaction (DDI)

Amyotrophic Lateral Sclerosis

United States
All India Institute of Medical Sciences, Bhubaneswar
Indian Council of Medical Research

Recruiting

Comparison of Antidepressant Augmentation With Amantadine vs Pramipexole vs Quetiapine in Treatment Resistant Depression (APQ-TRD)

Treatment Resistant Depression

India
Newron Pharmaceuticals SPA

Completed

MOTION, Safinamide in Early IPD, as add-on to Dopamine Agonist (MOTION)

Idiopathic Parkinson's Disease

United States, Spain, Brazil, Peru, Colombia, Germany, Argentina, India, Croatia, Czech Republic, Italy, South Africa, Finland, Portugal, Canada, Slovakia, Bulgaria, Chile, Mexico, Poland
Novartis Pharmaceuticals

Completed

A 26-week Treatment Randomized, Double-blind, Double Dummy Study to Assess the Efficacy and Safety of QVA149

Chronic Obstructive Pulmonary Disease

China, Argentina, Taiwan, Chile

Search clinical trials for: pramipexol

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ukraine

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations